Previous close | 0.1000 |
Open | 0.0500 |
Bid | 0.0000 |
Ask | 0.1500 |
Strike | 17.50 |
Expiry date | 2024-05-17 |
Day's range | 0.0500 - 0.1000 |
Contract range | N/A |
Volume | |
Open interest | 1.39k |
There's no doubt that money can be made by owning shares of unprofitable businesses. For example, although Amazon.com...
BOSTON, May 09, 2024--Astria Therapeutics, Inc. (NASDAQ:ATXS), a biopharmaceutical company focused on developing life-changing therapies for allergic and immunological diseases, today reported financial results for the first quarter ended March 31, 2024, and provided a corporate update.
BOSTON, May 08, 2024--Astria Therapeutics, Inc. (NASDAQ:ATXS), a biopharmaceutical company focused on developing life-changing therapies for allergic and immunological diseases, today announced that it will present information on the preclinical profile of STAR-0310 at the upcoming Society for Investigative Dermatology (SID) Annual Meeting in Dallas, Texas on May 16, 2024.